Adaptive resistance to targeted therapies in cancer

It is widely acknowledged that there is a need for molecular profiling in non-small-cell lung cancer. For example, treatment based on EGFR mutation status has attained successful results. However, in spite of excellent initial response to oral EGFR tyrosine kinase inhibitors (TKIs), progression-free...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transl Lung Cancer Res
Hauptverfasser: Rosell, Rafael, Karachaliou, Niki, Morales-Espinosa, Daniela, Costa, Carlota, Molina, Miguel Angel, Sansano, Irene, Gasco, Amaya, Viteri, Santiago, Massuti, Bartomeu, Wei, Jia, González Cao, María, Martínez Bueno, Alejandro
Format: Artigo
Sprache:Inglês
Veröffentlicht: Pioneer Bioscience Publishing Company 2013
Schlagworte:
Review Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367602/
https://ncbi.nlm.nih.gov/pubmed/25806228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2012.12.08
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge